Mercado de síntesis genética en Oriente Medio y África: tendencias de la industria y pronóstico hasta 2029

Análisis y perspectivas del mercado de síntesis genética en Oriente Medio y África

La síntesis genética es el proceso de creación de genes artificiales en un laboratorio mediante biología sintética. La generación de proteínas recombinantes es una de las numerosas aplicaciones de la tecnología del ADN recombinante, en la que la síntesis genética se perfila como un instrumento clave. Los métodos tradicionales de clonación y mutagénesis están siendo rápidamente reemplazados por la síntesis genética de novo, que también permite la producción de ácidos nucleicos para los que no existe una plantilla.

Se espera que el mercado de síntesis genética de Oriente Medio y África gane crecimiento de mercado en el período de pronóstico de 2022 a 2029. Data Bridge Market Research analiza que el mercado está creciendo con una CAGR del 17,4% en el período de pronóstico de 2022 a 2029 y se espera que alcance los USD 166,43 millones para 2029 desde USD 45,53 millones en 2021.

Definición de mercado

La síntesis génica se refiere a la síntesis química de la hebra de ADN base por base. A diferencia de la replicación del ADN que ocurre en las células o mediante la reacción en cadena de la polimerasa (PCR) , la síntesis génica no requiere una hebra molde. En cambio, la síntesis génica implica la adición gradual de nucleótidos a una molécula monocatenaria, que luego sirve como plantilla para la creación de una hebra complementaria. La síntesis génica es la tecnología fundamental sobre la que se ha construido el campo de la biología sintética.

Dinámica del mercado de síntesis de genes

En esta sección se aborda la comprensión de los factores impulsores, las oportunidades, las limitaciones y los desafíos del mercado. Todo esto se analiza en detalle a continuación:

Conductores

• AUMENTO DE LA PREVALENCIA DE ENFERMEDADES INFECCIOSAS CRÓNICAS

Las enfermedades bacterianas y virales se están expandiendo rápidamente debido a la creciente prevalencia de enfermedades infecciosas en todo el mundo. Como resultado, ha aumentado la demanda de terapias nuevas y efectivas para luchar contra estas enfermedades mortales. Estas enfermedades se pueden curar mediante el uso de medicamentos químicos y terapias biológicas, incluida la terapia génica. Al aplicar la genómica, se ha mejorado el manejo de las enfermedades infecciosas y endémicas. También nos permite comprender la resistencia emergente a los medicamentos e identificar objetivos para nuevas terapias y vacunas. Para el tratamiento de enfermedades infecciosas, la terapia génica ha atraído a muchos investigadores, ya que se puede tratar mediante el uso de tecnología de ADN recombinante, ribozimas de ADN y ARN y anticuerpos de cadena simple.

A medida que aumenta la prevalencia de enfermedades infecciosas crónicas a nivel mundial, también aumenta la demanda de vacunas y terapias génicas efectivas, lo que ha aumentado la demanda de genes nuevos con una aplicación significativa para actividades de investigación y fabricación de medicamentos y vacunas. Por lo tanto, la creciente prevalencia de enfermedades infecciosas actúa como impulsor del crecimiento del mercado de síntesis génica.

• AUMENTO DE LA ADOPCIÓN DE LA TERAPIA GÉNICA

La terapia génica es una técnica avanzada que incluye el uso de varios genes para la prevención de un tipo particular de enfermedad. La técnica implica la inserción de genes en las células del paciente en lugar de medicamentos y cirugía. Debido a la creciente demanda de resultados terapéuticos novedosos y duraderos, la adopción de la terapia génica está aumentando. Las terapias génicas requieren construcciones de genes sintéticos, entre otros productos genéticos, para acelerar el desarrollo de la terapia génica. Debido al aumento de las enfermedades genéticas, la demanda de una cura adecuada es un factor importante y, con la ayuda de la terapia génica, se puede curar un tipo particular de enfermedad.

Debido a la creciente demanda, los líderes se centran constantemente en producir productos de terapia genética, lograr aprobaciones y autorizaciones de comercialización.

Lifesaving medicines and therapies are in huge demand to provide quality life to different kinds of patients. These rising numbers of patients are largely dependent upon the gene therapies available to achieve a proper cure. To manufacture gene therapies, synthetic and novel genes are required, which can be achieved by the gene synthesis technique. Thus, the rising adoption of gene therapy is expected to act as a driver for the gene synthesis market.

• EXPANSION OF SYNTHETIC BIOLOGY

The incorporation of engineering principles into biology is termed synthetic biology. DNA genome can be reassembled with the help of synthetic biology as it involves the chemical synthesis of DNA by combining it with its genome. Oligonucleotides can be constructed in a short period by incorporating the usage of gene synthesis services, software, and consumables. As synthetic biology products' demand increases worldwide, gene synthesis products and services are also increasing.

Thus, due to its effective and innovative products, the demand for synthetic biology products is increasing globally, which is expected to act as a driving factor for the gene synthesis market.

Opportunities

•  RISING HEALTHCARE EXPENDITURE

Healthcare expenditure has increased worldwide as people's disposable income in various countries is increasing. Moreover, to accomplish the population requirements, government bodies and healthcare organizations are taking the initiative by virtue of accelerating healthcare expenditure.

Also, the strategic initiatives taken by key market players will provide structural integrity and future opportunities for the medical device testing market in the forecast period of 2022-2029.

Restraints/Challenges

HIGH COST OF THE GENE SYNTHESIS PROCESS

However, the barriers to the gene synthesis techniques and the high cost of the gene synthesis process in some regions may impede the less growth of the gene synthesis procedures hampering the growth of the market. Additionally, high competition in medical technology industries and long lead time for the overseas qualification can be challenging factors for the growth of the market

This gene synthesis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the gene synthesis market, contact Data Bridge Market Research for an Analyst Brief. Our team will help you to make an informed market decision to achieve market growth.

Recent Development

• In December 2020, Twist Bioscience launched clonal-ready gene fragments to complete the offering of genes. The fragments launched can be used with adapters or without adapters to build up the perfect clones. The clonal-ready gene fragments are compatible with the protein expression pathways, enzyme engineering, and gene expression, among others.
• In 2020, according to an article published in an ACS journal, a total estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths were reported worldwide. This suggests that cancer coverage is suboptimal, and there is a great need to implement high cancer coverage all over the world.

Middle East and Africa Gene Synthesis Market Scope

The Middle East and Africa gene synthesis market are segmented into component, gene type, gene synthesis type, application, method, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Component

• Synthesizers
• Consumables
• Software & services

On the basis of component, the Middle East and Africa gene synthesis market is segmented into synthesizers, consumables, and software & services.

Gene Type

• Standard gene
• Express gene
• Complex gene
• Others

On the basis of gene type, the Middle East and Africa gene synthesis market is segmented into the standard gene, express gene, complex gene and others.

Gene Synthesis Type

• Gene library synthesis
• Custom gene synthesis

On the basis of gene synthesis type, the Middle East and Africa gene synthesis market is segmented into gene library synthesis and custom gene synthesis.

Application

• Synthetic biology,
• Genetic engineering,
• Vaccine design,
• Therapeutics antibodies
• Others

On the basis of application, the Middle East and Africa gene synthesis market is segmented into synthetic biology, genetic engineering, vaccine design, therapeutics antibodies, and others.

Method

• Solid based synthesis,
• Chip-based DNA synthesis
• PCR-based enzyme synthesis

On the basis of the method, the Middle East and Africa gene synthesis market is segmented into solid based synthesis, chip-based DNA synthesis, and PCR-based enzyme synthesis.

End User

• Academic & research institutes,
• Diagnostics laboratories,
• Biotech & pharmaceutical companies
• Others

On the basis of end users, the Middle East and Africa gene synthesis market is segmented into academic & research institutes, diagnostics laboratories, biotech & pharmaceutical companies, and others.

Distribution Channel

• Direct tender
• Online distribution
• Third party distributors

On the basis of distribution channels, the Middle East and Africa gene synthesis market is segmented into direct tender, online distribution, and third party distributors.

Gene Synthesis Market Regional Analysis/Insights               

The gene synthesis market is analyzed, and market size insights and trends are provided by the country, component, gene type, gene synthesis type, application, method, end user, and distribution channel, as referenced above.

Saudi Arabia dominates the gene synthesis market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the rising need for the verification and validation of gene synthesis processes in the region, and rapid research development is boosting the market

The country section of the report also provides individual market-impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, disease epidemiology, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of global brands and their challenges faced due to high competition from local and domestic brands, and the impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Gene Synthesis Market Share Analysis

The gene synthesis market competitive landscape provides details by the competitors. Details include company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies focus on the gene synthesis market.

Some of the major players operating in the gene synthesis market are ATDBio Ltd (Subsidiary of Biotage), General Biosystems, Inc., MACROGEN CO., LTD., Boster Biological Technology, Creative Biogene, Bioneer Pacific, exonbio, trenzyme GmbH, Twist Bioscience, BioCat GmbH (Subsidiary of AddLife AB), OriGene Technologies, Inc., Integrated DNA Technologies, Inc. 9Subsidiary of Danaher Corporation), Eurofins Scientific, NZYTech, Lda. - Genes and Enzymes, Ansa Biotechnologies, Inc., Thermo Fisher Scientific, Genescript, Synbio Technologies, Proteogenix, Bio Basic Inc., ATG:biosynthetics GmbH, Merck KGaA, Kaneka Eurogentec S.A, Ginkgo Bioworks, Bbi-lifesciences, Evonetix, ProMab Biotechnologies, Inc., GCC Biotech (INDIA) Pvt. Ltd., CSBio, Azenta US, Inc., and among others.

Research Methodology

La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con tamaños de muestra grandes. Los datos del mercado se analizan y estiman utilizando modelos estadísticos y coherentes del mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Aparte de esto, los modelos de datos incluyen la cuadrícula de posicionamiento de proveedores, el análisis de la línea de tiempo del mercado, la descripción general y la guía del mercado, la cuadrícula de posicionamiento de la empresa, el análisis de la participación de mercado de la empresa, los estándares de medición, Oriente Medio y África frente a la región y el análisis de la participación de los proveedores. Solicite una llamada de un analista en caso de tener más consultas.

SKU-62812